Takeda Austria GmbH
Takeda Austria GmbH is a drug establishment in Linz, Austria, registered with the US FDA under FEI 3001157285. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging. 18 EU/UK GMP certificates are matched to this site, 7 inspected within the last three years.
Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology
Registered operations
Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.
GMP documents matched to this site (18)
| Document | Authority | Inspection | Source |
|---|---|---|---|
484005-103627759 GMP certificate | Competent authority of Austria | 14 Feb 2025 within 3-year review window | EudraGMDP |
480050-103601053 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-105225740 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-105072353 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-105225172 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-104373252 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-105141114 GMP certificate | Competent authority of Austria | 13 Feb 2025 within 3-year review window | EudraGMDP |
480050-101991887 GMP certificate | Competent authority of Austria | 24 Aug 2023 outside 3-year review window | EudraGMDP |
480050-102752263 GMP certificate | Competent authority of Austria | 24 Aug 2023 outside 3-year review window | EudraGMDP |
480050-101977405 GMP certificate | Competent authority of Austria | 24 Aug 2023 outside 3-year review window | EudraGMDP |
480050-101906786 GMP certificate | Competent authority of Austria | 24 Aug 2023 outside 3-year review window | EudraGMDP |
484005-101974379 GMP certificate | Competent authority of Austria | 24 Aug 2023 outside 3-year review window | EudraGMDP |
480050-103263245 GMP certificate | Competent authority of Austria | 21 Aug 2023 outside 3-year review window | EudraGMDP |
480050-103852767 GMP certificate | Competent authority of Austria | 21 Aug 2023 outside 3-year review window | EudraGMDP |
480050-102873199 GMP certificate | Competent authority of Austria | 21 Aug 2023 outside 3-year review window | EudraGMDP |
480050-101910621 GMP certificate | Competent authority of Austria | 14 Jan 2021 outside 3-year review window | EudraGMDP |
480050-101558683 GMP certificate | Competent authority of Austria | 14 Jan 2021 outside 3-year review window | EudraGMDP |
480050-101183595 GMP certificate | Competent authority of Austria | 14 Jan 2021 outside 3-year review window | EudraGMDP |
A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.
What this page does not show
- Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
- Capacity, scale, price or current availability: no regulator publishes these.
- FDA inspection classifications for this site, which are not yet linked.